PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/

Institutional investor · Portfolio as of Q2 2020

SEC EDGAR SourceSEC Filings

Top Holdings306 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ELI LILLY & CO

39.6M$6.5B5.6%$104.89+46.36%
7 qtrssince 2018-Q4
Decreased
0

MICROSOFT CORP

23.9M$4.9B4.2%$93.93+101.70%
7 qtrssince 2018-Q4
Decreased
0

ADOBE INC

11M$4.8B4.1%$226.24+92.41%
7 qtrssince 2018-Q4
Decreased
0

AMGEN INC

18M$4.2B3.6%$155.16+26.30%
7 qtrssince 2018-Q4
Decreased
0

BIOGEN IDEC INC

15.6M$4.2B3.6%$301.43-11.24%
7 qtrssince 2018-Q4
Decreased
0

TEXAS INSTRUMENTS INC

26.4M$3.3B2.9%$76.19+40.21%
7 qtrssince 2018-Q4
Decreased
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

13.2M$2.8B2.4%$128.99+57.36%
7 qtrssince 2018-Q4
Decreased
0
AZNAZN
ADR

ASTRAZENECA PLC

53.7M$2.8B2.4%$62.04+52.44%
7 qtrssince 2018-Q4
Decreased
0

MICRON TECHNOLOGY INC

51.5M$2.7B2.3%$30.80+55.71%
7 qtrssince 2018-Q4
Decreased
0

SOUTHWEST AIRLINES CO

69.2M$2.4B2.0%$42.56-23.40%
7 qtrssince 2018-Q4
Increased
56

ALPHABET INC-CL A

1.6M$2.3B2.0%$51.95+33.47%
7 qtrssince 2018-Q4
Decreased
0
SONYSONY
ADR

SONY CORP-SPONSORED ADR

33M$2.3B2.0%$9.23+44.42%
7 qtrssince 2018-Q4
Decreased
0

BIOMARIN PHARMACEUTICAL INC

17.9M$2.2B1.9%$82.99+47.22%
7 qtrssince 2018-Q4
Increased
50
NVSNVS
ADR

NOVARTIS AG-SPONSORED ADR

23.3M$2B1.7%$59.98+19.63%
7 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL C

1.4M$2B1.7%$51.47+34.51%
7 qtrssince 2018-Q4
Decreased
0

KLA CORP

10M$1.9B1.7%$8.14+124.10%
7 qtrssince 2018-Q4
Decreased
0

QUALCOMM INC

21.2M$1.9B1.7%$48.04+64.76%
7 qtrssince 2018-Q4
Decreased
0

FEDEX CORP

13.6M$1.9B1.6%$140.04-13.17%
7 qtrssince 2018-Q4
Decreased
0

THERMO FISHER SCIENTIFIC INC

4.7M$1.7B1.5%$219.64+57.48%
7 qtrssince 2018-Q4
Decreased
0

JPMORGAN CHASE & CO

17.3M$1.6B1.4%$79.22+0.72%
7 qtrssince 2018-Q4
Decreased
0
$116.5B
AUM
306
Positions
Q2 2020
Filing
Rating · 3.5
Quarterly Portfolio Change
+10%Q1'19$135.9B-0%Q2'19$135.2B-8%Q3'19$125B+10%Q4'19$137.9B-26%Q1'20$102B+14%Q2'20$116.5B
Activity profile
$ moved · Q2'20
New5%Increased13%Decreased79%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q6%1-4Q10%1-2Y84%2Y+0%

PRIMECAP MANAGEMENT CO/CA/ manages $116.5B across 306 positions as of Q2 2020. Top holdings: LLY (5.6%), MSFT (4.2%), ADBE (4.1%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 3.5/5.0.

Q2 2020 Summary

Active quarter - 20 new positions, 10 exits, 58 increased. Top move: LUV (INCREASED, conviction 56). Portfolio: $116.5B across 306 positions.

Top holdings by portfolio weight

Total AUM$117B
LLY5.58%
MSFT4.17%
ADBE4.11%
AMGN3.64%
BIIB3.59%
TXN2.87%
BABA2.45%
AZN2.44%
MU2.28%
LUV2.03%
Other1.99%

Portfolio allocation by GICS sector

Sectors11
Technology30.84%
Healthcare28.29%
Industrials9.99%
Consumer Cyclical9.32%
Financial Services7.43%
Unknown6.84%
Communication Services5.78%
Basic Materials0.66%
Energy0.50%
Consumer Defensive0.36%
Other0.01%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record68
Conviction37
Concentration64
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
COPCOPCONOCOPHILLIPS
Q3 2024 Q2 2026+8.7M shares+$872.8M
8Q
USFDUSFDUS FOODS HOLDING CORP
Q3 2024 Q2 2026+3.9M shares+$400.8M
7Q
SCHWSCHWSCHWAB (CHARLES) CORP
Q4 2024 Q2 2026+24.1M shares+$2.3B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used